Trial Profile
A Confirmatory Multicenter, Double-Blind, Randomized, Placebo Controlled Study of the Use of Quetiapine Fumarate (SEROQUEL) in the Treatment of Patients With Bipolar Depression.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Jan 2013
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar depression
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 08 Apr 2009 New trial record